Willis Towers Watson: Margins Expanding But Growth Faces Pressure

Willis Towers Watson delivered solid Q2 results with margin expansion and strong cost discipline, alleviating some sector concerns and driving a 5% stock jump. Organic revenue growth remains healthy at 5%, but premium inflation is normalizing, likely slowing future growth to mid-single digits. The company maintains a strong balance sheet, prioritizes aggressive buybacks, and is on track for $1.5 billion in repurchases this year.